Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 5/10/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Neil Berinstein?

Neil L. Berinstein

Assistant Vice President and Global Program Leader

Sanofi Pasteur Limited

HQ Phone:  (416) 667-2701

Direct Phone: (416) ***-****direct phone

Email: n***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Sanofi Pasteur Limited

1755 Steeles Avenue West

Toronto, Ontario,M2R 3T4

Canada

Company Description

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health an... more

Find other employees at this company (9,070)

Background Information

Employment History

Cancer Researcher and Clinician Scientist

Sunnybrook Health Sciences Centre


Vice President

CANVAC


Affiliations

Cancer Research Institute

Part of the Executive Steering Committee


Leukemia Research Fund

Member


ImmunoVaccine Technologies Inc.

Science Advisory Board


Biovest International , Inc.

Scientific Advisory Board Member


Spectrum

Scientific Advisor


Molecular Templates Inc

Scientific Advisory Board Member


Phacilitate Limited

Advisory Boards Member


Canadian Blood and Marrow Transplant Group

Board Member


School of Graduate Studies

Full Member


Hope for Health Foundation

Co-Founder


Accentia Biopharmaceuticals , Inc.

Scientific Advisory Board Member


Stanford University

Post-Doctoral Fellow


Education

Internal Medicine and Medical Oncology

University of Toronto


M.D.

Department of Medicine


MD

University of Manitoba


pre-medical degree

University of Manitoba


Web References(138 Total References)


About IRX - IRX Therapeutics

irxtherapeutics.com [cached]

Neil L. Berinstein, MD, FRCP(C), ABIM
Neil L. Berinstein, MD, FRCP(C), ABIM was appointed Chief Scientific Advisor in January 2010. Prior to joining IRX Therapeutics, Dr. Berinstein served as Assistant Vice President and Global Program Leader at Sanofi Pasteur, where he was in charge of leading the development of Sanofi's cancer vaccines both strategically and operationally. Dr. Berinstein was responsible for interacting with international collaborators and leading researchers who were collaborating with Sanofi Pasteur either at preclinical or clinical levels. He saw to completion several multicenter phase 1 and phase 2 studies in Canada and the US in colorectal and melanoma projects. Dr. Berinstein currently holds multiple academic and professional positions, including Professor in the Department of Medicine, University of Toronto, and Affiliate Scientist, Biological Sciences at the Odette Cancer Centre of the Sunnybrook Health Sciences Centre, Toronto. He was the Vice President of the Cancer Vaccine Consortium sponsored by the Sabin Institute and more recently is part of the executive steering committee of the Cancer Research Institute (CRI)-sponsored Cancer Vaccine Consortium. He was formerly a member and leader of the scientific review committee of the Leukemia Research Fund. Dr. Berinstein has been the recipient of numerous grants in his research career and has published 6 book chapters, and over 100 peer-reviewed, invited or review papers to date. He received his premedical degree and Medical Doctorate from the University of Manitoba and further specialty and research training at the University of Toronto and Stanford University.


About IRX - IRX Therapeutics

irxtherapeutics.com [cached]

Neil L. Berinstein, MD, FRCP(C), ABIM
Neil L. Berinstein, MD, FRCP(C), ABIM was appointed Chief Scientific Advisor in January 2010. Prior to joining IRX Therapeutics, Dr. Berinstein served as Assistant Vice President and Global Program Leader at Sanofi Pasteur, where he was in charge of leading the development of Sanofi's cancer vaccines both strategically and operationally. Dr. Berinstein was responsible for interacting with international collaborators and leading researchers who were collaborating with Sanofi Pasteur either at preclinical or clinical levels. He saw to completion several multicenter phase 1 and phase 2 studies in Canada and the US in colorectal and melanoma projects. Dr. Berinstein currently holds multiple academic and professional positions, including Professor in the Department of Medicine, University of Toronto, and Affiliate Scientist, Biological Sciences at the Odette Cancer Centre of the Sunnybrook Health Sciences Centre, Toronto. He was the Vice President of the Cancer Vaccine Consortium sponsored by the Sabin Institute and more recently is part of the executive steering committee of the Cancer Research Institute (CRI)-sponsored Cancer Vaccine Consortium. He was formerly a member and leader of the scientific review committee of the Leukemia Research Fund. Dr. Berinstein has been the recipient of numerous grants in his research career and has published 6 book chapters, and over 100 peer-reviewed, invited or review papers to date. He received his premedical degree and Medical Doctorate from the University of Manitoba and further specialty and research training at the University of Toronto and Stanford University.


Immunovaccine : Science Advisory

www.imvaccine.com [cached]

Dr. Neil Berinstein
Dr. Neil Berinstein Science Advisory Board Dr. Berinstein obtained his Medical Doctoral Degree at the University of Manitoba and completed training programs at the University of Toronto in Internal Medicine and Medical Oncology and at Stanford University in the area of Immunotherapy for cancer. Dr. Berinstein was a founding director of the Advanced Therapeutics Program at the Toronto-Sunnybrook Regional Cancer Centre with a long track record in fundamental research and a significant publication record in the area of normal and malignant B cell biology and cancer immunotherapy. Dr. Berinstein was Global Program Head of Sanofi Pasteur's cancer vaccine program from 1998-2009. He is a Full Professor in the Department of Medicine at the University of Toronto and is currently the Director of Translational Research at the Ontario Institute for Cancer Research. He is a member of the Executive Committee of the Cancer Research Institute Cancer Immunotherapy Consortium. He has published over 100 research papers and a similar number of research abstracts.


Scientific Advisory Board

www.biovest.com [cached]

Neil L. Berinstein, M.D., Professor of Medicine, University of Toronto and Director of Translational Research, Ontario Institute for Cancer Research - Dr. Berinstein is a global pioneer in cancer vaccines, having formerly served as Assistant Vice President and Global Program Leader at Sanofi Pasteur, leading the development of Sanofi's cancer vaccines both strategically and operationally.
He currently serves as part of the Executive Steering Committee of the Cancer Research Institute-sponsored Cancer Immunotherapy Consortium and was formerly a member and leader of the scientific review committee of the Leukemia Research Fund. Dr. Berinstein is the recipient of numerous grants in his research career and has published six book chapters, and over 100 peer-reviewed, invited or review papers to date.


dermatologyupdate.com

Dr. Neil Berinstein
Dr. Neil Berinstein Dr. Neil Berinstein Dr. Neil Berinstein Oncologist, Toronto, Ontario, Canada Dr. Neil Berinstein is the Global Head of the Cancer Vaccine Program at Sanofi-Pasteur, Toronto-Sunnybrook Regional Cancer Centre. His research interests include immunotherapy in the treatment of cancer.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory